Clinical Trial Update: Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating LY3437943 versus placebo in adults with obesity or those who are overweight; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• LY3437943

Snippet

Sponsor: Hudson Biotech | Conditions: Obesity | Phase 2 | Status: RECRUITING